Eton Pharmaceuticals eases terms on SWK credit line
Eton Pharmaceuticals entered into a sixth amendment to its credit agreement with SWK Funding LLC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Eton Pharmaceuticals entered into a sixth amendment to its credit agreement with SWK Funding LLC. The amendment lowers the loan’s interest rate from Secured Overnight Financing Rate (SOFR) plus 6.75% to SOFR plus 6.55% and reduces the SOFR floor from 5.0% to 2.75%.
The interest-only period was extended to November 2026, and Eton may choose to begin principal payments in May 2026 or defer them until November 2026. No fees were paid to SWK in connection with this amendment, and the loan’s maturity date remains in December 2027.
8-K Event Classification
3 items: 1.01, 2.03, 9.01
3 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
New interest margin: SOFR + 6.55%
Prior interest margin: SOFR + 6.75%
New SOFR floor: 2.75%
+3 more
6 metrics
New interest margin
SOFR + 6.55%
Amended SWK Credit Agreement
Prior interest margin
SOFR + 6.75%
Before sixth amendment
New SOFR floor
2.75%
Amended loan terms
Prior SOFR floor
5.0%
Original SWK Credit Agreement terms
Interest-only extension
To November 2026
Interest-only period for SWK loan
Loan maturity
December 2027
Maturity of amended SWK Credit Agreement
Key Terms
Secured Overnight Financing Rate, SOFR floor, interest only period, Material Definitive Agreement, +1 more
5 terms
Secured Overnight Financing Rate financial
"the interest rate was reduced from a Secured Overnight Financing Rate (“SOFR”) plus 6.75%"
A secured overnight financing rate (SOFR) is a daily benchmark interest rate that reflects the cost of borrowing cash overnight using U.S. Treasury securities as collateral. Think of it as the market price to “rent” cash for a day with a very safe pledge, similar to paying a short-term rental fee for money backed by government bonds. Investors track SOFR because it underpins pricing for loans, bonds and derivatives, so movements change borrowing costs, interest income and the valuation of interest-rate–linked positions.
SOFR floor financial
"with the SOFR floor reduced to 2.75% from the previous 5.0%"
interest only period financial
"Further, the interest only period was extended to November 2026"
Material Definitive Agreement regulatory
"Item 1.01 Entry into a Material Definitive Agreement"
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What credit agreement change did Eton Pharmaceuticals (ETON) announce?
Eton Pharmaceuticals amended its credit agreement with SWK Funding LLC. The change lowers the interest rate spread and SOFR floor, extends the interest-only period, and keeps the existing December 2027 maturity, improving loan terms without paying additional fees to the lender.
How did the interest rate terms change for Eton Pharmaceuticals’ SWK loan?
The loan’s interest rate decreased from SOFR plus 6.75% to SOFR plus 6.55%. In addition, the SOFR floor, which is the minimum reference rate applied, was reduced from 5.0% to 2.75%, potentially lowering Eton’s overall borrowing cost when market rates are low.
What happened to the interest-only period in Eton Pharmaceuticals’ amended loan?
The interest-only period was extended to November 2026. Eton Pharmaceuticals can start making principal payments in May 2026 or delay those payments until November 2026, giving the company more flexibility in managing cash flow over the next several years.
Did Eton Pharmaceuticals pay any fees for the sixth amendment to its credit agreement?
Eton Pharmaceuticals did not pay any fees to SWK Funding LLC in connection with the sixth amendment. The company obtained more favorable interest terms and an extended interest-only period while keeping the maturity date unchanged, without incurring additional amendment-related costs.
When does Eton Pharmaceuticals’ amended SWK credit agreement mature?
The amended SWK credit agreement continues to mature in December 2027. While the interest rate terms and interest-only period were improved, the final maturity date of the loan remained the same, keeping the overall term length of the debt facility unchanged.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates